Elisabeth Schaffner-Reckinger

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsProteins and peptidesCancer cell biologyBiomolecular modelling and designPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 11, 2026
K-Ras controls asymmetric cell divisions from the primary cilium.

|Nov 18, 2025
Development of a Genetically Encoded and Potent PDE6D Inhibitor.

Atanasio Gómez-Mulas, Elisabeth Schaffner-Reckinger, Hanne Peeters

|Nov 17, 2025
The impact of RAS on cell differentiation in health and disease.

Carla Jane Duval, Sara Bottone, Elisabeth Schaffner-Reckinger

|May 17, 2024
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit KRAS Mutant Cancer Cell Growth.

Pelin Kaya, Elisabeth Schaffner-Reckinger, Ganesh Babu Manoharan

|Feb 26, 2022
Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay.

Claudia Cipriani, Maria Pires Pacheco, Ali Kishk

|Feb 23, 2021
L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness.

Raquel A C Machado, Dunja Stojevski, Sébastien De Landtsheer

Pageof 1

Frequent Collaborators

5 joint publications

Daniel Kwaku Abankwa

2 joint publications

Thomas Sauter

1 joint publications

Claudia Cipriani

1 joint publications

Maria Pires Pacheco